U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07916350) titled 'A Study of the Safety and Effectiveness of a Compound Steep-Pulse Therapy Apparatus for Malignant Liver Tumors' on Oct. 23.
Brief Summary: This prospective, multicenter, randomized, parallel-group, open-label, noninferiority study compares the safety and efficacy of the Compound Steep-Pulse Therapy Apparatus with radiofrequency ablation in adults with malignant liver tumors. Eligible participants are randomly assigned in a 1:1 ratio to the test group or the control group using a web-based central randomization system, with stratification by tumor diameter and tumor type.
The primary outcome is the ablation success rate at 1 month af...